The Utrogestan and hMG protocol in patients with polycystic ovarian syndrome undergoing controlled ovarian hyperstimulation during IVF/ICSI treatments

Poor oocyte quality is a main concern for decreased reproductive outcomes in women with polycystic ovarian syndrome (PCOS) during controlled ovarian hyperstimulation (COH). A primary way to improve oocyte quality is to optimize the COH protocol. It was demonstrated that the viable embryo rate per oo...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Xiuxian, Ye, Hongjuan, Fu, Yonglun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
5600
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4956813/
https://www.ncbi.nlm.nih.gov/pubmed/27428219
http://dx.doi.org/10.1097/MD.0000000000004193

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4956813/
https://www.ncbi.nlm.nih.gov/pubmed/27428219
http://dx.doi.org/10.1097/MD.0000000000004193

Ejemplares similares